# OnCo record antiangiogenic (technology). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/technologies/antiangiogenic/>
  a schema:MedicalTherapy ;
  onco:kind "technology" ;
  schema:identifier "antiangiogenic" ;
  schema:name "Anti-angiogenic therapy"@en ;
  schema:description "Anti-angiogenic therapy cuts off the tumour's blood supply; it is now mostly used to help immunotherapy work better."@en ;
  schema:url <https://onco.cc/technologies/antiangiogenic/> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Angiogenesis_inhibitor> ;
  owl:sameAs <http://www.wikidata.org/entity/Q574834> ;
  schema:citation <https://en.wikipedia.org/wiki/Angiogenesis_inhibitor> ;
  onco:status "standard-of-care" ;
  onco:related <https://onco.cc/technologies/angiogenesis-models/>, <https://onco.cc/technologies/tumour-mechanics-models/> ;
  onco:cancers <https://onco.cc/cancers/rcc/>, <https://onco.cc/cancers/hcc/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/endometrial/> ;
  onco:sections <https://onco.cc/fronts/targeted-therapy/> ;
  onco:targets <https://onco.cc/targets/vegf/> ;
  onco:companies <https://onco.cc/companies/compass-therapeutics/> .